Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
Oct. 31, 2020
Apr. 30, 2020
Current Assets    
Cash $ 480,065 $ 236,668
Inventory 170,486 78,650
Other 3,020
Total Current Assets 650,551 318,338
Goodwill 2,466,073 2,466,073
Trademark 20,000 20,000
Other 3,853 3,853
TOTAL ASSETS 3,140,477 2,808,264
Current Liabilities    
Accounts payable 355,092 249,050
Accrued Expenses 71,465 89,342
Notes Payable 354,527 118,771
Due to Related Party 329,777 333,684
Customer deposits 66,205 38,419
Derivative liability 812,390
Total Current Liabilities 1,989,456 829,266
Convertible debentures, net of discount of $581,599 18,401 450,000
Commitments and contingencies
Stockholders' Equity    
Series A Preferred Stock - shares authorized 2,200,000; outstanding 208,704; Series B Preferred Stock - shares authorized 4,300,000; outstanding 3,681,623 38,903 38,903
Common stock - shares authorized 500,000,000; outstanding 20,721,535 and 20,011,091 20,722 20,011
Additional paid-in capital 4,752,273 4,043,837
Accumulated deficit (3,679,278) (2,573,753)
Total Stockholders' Equity 1,132,620 1,528,998
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,140,477 $ 2,808,264